New Lundbeck exec to get firm's next research leg started

Lundbeck's decision to find a new head of research and development is part of a major reorganization of the company's R&D unit, which has been going on for a while, the Danish pharmaceutical firm's Executive Vice President & Head of Research & Development Johan Luthman tells MedWatch.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck poaches CSO from US biotech firm
For subscribers